Intestinal Failure (New York, N.Y.) · 2026
Healthcare cost of home parenteral nutrition and intestinal transplantation for paediatric chronic intestinal failure in Singapore.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chiou Fang Kuan, Koh Ye Xin, Ng Lay Queen, Goh Lynette, Low Yee, Chen Yong, Wai Pui Ling, Ng Zhen Ling, Sudan Debra, Jeyaraj Prema Raj
Аннотация
BACKGROUND: Chronic intestinal failure (IF) and long-term parenteral nutrition (PN) impose significant financial burden on patients and the healthcare system. This study aimed to evaluate the healthcare cost of home-PN (HPN) and intestinal transplantation (ITx) at a single-centre.
METHODS: This was a cost-of-illness evaluation based on retrospective analysis of billing records of patients (0-18 years) receiving HPN in 2016-2025 (excluding hospital-PN). Annual HPN cost was calculated based on average cost during the latest 3 years of HPN. Cost of ITx (since 2022) included index hospitalisation for transplant surgery and all healthcare costs in the first 3 years following ITx (ITx-Y1/Y2/Y3).
RESULTS: Out of 35 patients with chronic IF, 11 patients on HPN with dysmotility(n = 6) and short bowel syndrome(n = 5) were included (median PN-duration: 6.5 years), with 4 eventually receiving ITx. Annual cost of HPN for patients who weaned-off HPN(n = 3), versus patients who remained stable on HPN(n = 3), and patients who developed complications from irreversible IF(n = 5) was S$70,227(US$51,638)/year, S$114,359(US$84,088)/year and S$219,510(US$161,404)/year respectively. Comparatively, mean cost of index hospitalisation for ITx was S$226,316(US$166,409). Cost was highest in ITx-Y1 (S$511,905/US$376,401), followed by 66-67 % year-on-year reduction to S$172,178(US$126,601) in ITx-Y2, and S$56,152(US$41,288) in ITx-Y3. Post-transplant lymphoproliferative disorder and cytomegalovirus infection contributed to wide variation in costs in ITx-Y1.
CONCLUSIONS: Cost of HPN was highest in patients with irreversible IF. While ITx incurred the highest cost in ITx-Y1, there was substantial reduction in cost in the subsequent years, which may potentially be cost-saving in the long-term, as compared to continued HPN for patients with irreversible IF.
METHODS: This was a cost-of-illness evaluation based on retrospective analysis of billing records of patients (0-18 years) receiving HPN in 2016-2025 (excluding hospital-PN). Annual HPN cost was calculated based on average cost during the latest 3 years of HPN. Cost of ITx (since 2022) included index hospitalisation for transplant surgery and all healthcare costs in the first 3 years following ITx (ITx-Y1/Y2/Y3).
RESULTS: Out of 35 patients with chronic IF, 11 patients on HPN with dysmotility(n = 6) and short bowel syndrome(n = 5) were included (median PN-duration: 6.5 years), with 4 eventually receiving ITx. Annual cost of HPN for patients who weaned-off HPN(n = 3), versus patients who remained stable on HPN(n = 3), and patients who developed complications from irreversible IF(n = 5) was S$70,227(US$51,638)/year, S$114,359(US$84,088)/year and S$219,510(US$161,404)/year respectively. Comparatively, mean cost of index hospitalisation for ITx was S$226,316(US$166,409). Cost was highest in ITx-Y1 (S$511,905/US$376,401), followed by 66-67 % year-on-year reduction to S$172,178(US$126,601) in ITx-Y2, and S$56,152(US$41,288) in ITx-Y3. Post-transplant lymphoproliferative disorder and cytomegalovirus infection contributed to wide variation in costs in ITx-Y1.
CONCLUSIONS: Cost of HPN was highest in patients with irreversible IF. While ITx incurred the highest cost in ITx-Y1, there was substantial reduction in cost in the subsequent years, which may potentially be cost-saving in the long-term, as compared to continued HPN for patients with irreversible IF.